OXAZEPAM - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for oxazepam and what is the scope of patent protection?

Oxazepam is the generic ingredient in three branded drugs marketed by Actavis Elizabeth, Am Therap, Epic Pharma Llc, Ivax Sub Teva Pharms, Mylan, United Res Labs, Watson Labs, Watson Labs Teva, Alpharma Us Pharms, Quantum Pharmics, Parke Davis, and Sun Pharm Industries, and is included in twenty-four NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for oxazepam. Four suppliers are listed for this compound.

Summary for OXAZEPAM

US Patents:	0
Tradenames:	3
Applicants:	12
NDAs:	24
Drug Master File Entries:	8
Finished Product Suppliers / Packagers:	4
Raw Ingredient (Bulk) Api Vendors:	43
Clinical Trials:	15
Patent Applications:	7,061
Drug Prices:	Drug price trends for OXAZEPAM
What excipients (inactive ingredients) are in OXAZEPAM?	OXAZEPAM excipients list
DailyMed Link:	OXAZEPAM at DailyMed

See drug prices for OXAZEPAM

Recent Clinical Trials for OXAZEPAM

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Assistance Publique - Hôpitaux de Paris	Phase 2
Embera NeuroTherapeutics, Inc.	Phase 1/Phase 2
Rose Research Center, LLC	Phase 1/Phase 2

See all OXAZEPAM clinical trials

Pharmacology for OXAZEPAM

Drug Class	Benzodiazepine

Medical Subject Heading (MeSH) Categories for OXAZEPAM

Anti-Anxiety Agents
GABA Modulators
Hypnotics and Sedatives

Anatomical Therapeutic Chemical (ATC) Classes for OXAZEPAM

N05BA	Benzodiazepine derivatives
N05B	ANXIOLYTICS
N05	PSYCHOLEPTICS
N	Nervous system

US Patents and Regulatory Information for OXAZEPAM

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Mylan	OXAZEPAM	oxazepam	CAPSULE;ORAL	071714-001	Oct 20, 1987		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
United Res Labs	OXAZEPAM	oxazepam	CAPSULE;ORAL	071026-002	Aug 10, 1987	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Alpharma Us Pharms	SERAX	oxazepam	CAPSULE;ORAL	015539-004	Approved Prior to Jan 1, 1982		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for OXAZEPAM

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Alpharma Us Pharms	SERAX	oxazepam	CAPSULE;ORAL	015539-002	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Alpharma Us Pharms	SERAX	oxazepam	CAPSULE;ORAL	015539-006	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
Alpharma Us Pharms	SERAX	oxazepam	CAPSULE;ORAL	015539-004	Approved Prior to Jan 1, 1982	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.